Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

BACKGROUND: Dupuytren's disease is a common fibrotic condition of the hand that causes irreversible flexion contractures of the fingers, with no approved therapy for early stage disease. Our previous analysis of surgically-excised tissue defined tumour necrosis factor (TNF) as a potential thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanchahal, Jagdeep, Ball, Catherine, Davidson, Dominique, Williams, Lynn, Sones, William, McCann, Fiona E., Cabrita, Marisa, Swettenham, Jennifer, Cahoon, Neil J., Copsey, Bethan, Anne Francis, E., Taylor, Peter C., Black, Joanna, Barber, Vicki S., Dutton, Susan, Feldmann, Marc, Lamb, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085556/
https://www.ncbi.nlm.nih.gov/pubmed/29983350
http://dx.doi.org/10.1016/j.ebiom.2018.06.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085556/
https://www.ncbi.nlm.nih.gov/pubmed/29983350
http://dx.doi.org/10.1016/j.ebiom.2018.06.022

Ejemplares similares